Vydura is a medicine used to treat migraine with or without aura (unusual visual or other sensory experiences) in adults. It is also used to prevent migraine in adults who have at least 4 migraines attacks a month. Vydura contains the active substance rimegepant.
Therapeutic Indication
### Therapeutic indication Vydura is indicated for the - Acute treatment of migraine with or without aura in adults; - Preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.
Therapeutic Area (MeSH)
ATC Code
N02CD06
ATC Item
rimegepant
Pharmacotherapeutic Group
Antimigraine preparations, calcitonin gene-related peptide (CGRP) antagonists
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Rimegepant | N/A | 瑞美吉泮 |
EMA Name
Vydura
Medicine Name
Vydura
Aliases
N/A